![Murali Prahalad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Murali Prahalad
Directeur Général chez
Iridia, Inc.
Fortune : 742 114 $ au 31/05/2026
Profil
Murali K.
Prahalad is President & Chief Executive Officer at Iridia, Inc. since 2019.
Dr. Prahalad is Director at Epic Sciences, Inc. since 2019.
Dr. Prahalad is Director at Maravai Life Sciences, Inc. Dr. Prahalad was Independent Director at Maravai Lifesciences Holdings, Inc. from 2016 to 2025.
Dr. Prahalad was Vice President-Business Development at Sequenom, Inc. Dr. Prahalad was Vice President-Corporate Strategy at Life Technologies Corp.
from 2012 to 2013.
Dr. Prahalad completed undergraduate studies at the University of Michigan.
Dr. Prahalad completed graduate and doctorate degrees at Harvard University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2025 | 154 607 ( 0,1 % ) | 742 114 $ | 31/05/2026 |
Postes actifs de Murali Prahalad
| Sociétés | Poste | Début |
|---|---|---|
Epic Sciences, Inc.
 Epic Sciences, Inc. Medical SpecialtiesHealth Technology Develops novel diagnostics to the treatment and management of cancer | Directeur/Membre du Conseil | 01/04/2019 |
Iridia, Inc.
 Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in bio technology | Directeur Général | 01/11/2019 |
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | - |
Anciens postes connus de Murali Prahalad
| Sociétés | Poste | Fin |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Directeur/Membre du Conseil | 27/10/2025 |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Corporate Officer/Principal | 01/01/2013 |
| SEQUENOM, INC. | Corporate Officer/Principal | - |
Formation de Murali Prahalad
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Develops novel diagnostics to the treatment and management of cancer | Health Technology |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Iridia, Inc.
Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in bio technology | Commercial Services |
Maravai Lifesciences Holdings, Inc.
 Maravai Lifesciences Holdings, Inc. BiotechnologyHealth Technology Develops and sells drug therapies, diagnostics and novel vaccines | Health Technology |
Choisissez Zonebourse 
